Liposome entrapment and immunogenic studies of a synthetic lipophilic multiple antigenic peptide bearing VP1 and VP3 domains of the hepatitis A virus:: a robust method for vaccine design

被引:31
作者
Haro, I
Pérez, S
García, M
Chan, WC
Ercilla, G
机构
[1] CSIC, Dept Quim Peptids & Prot, IIQAB, ES-08034 Barcelona, Spain
[2] Univ Nottingham, Sch Pharmaceut Sci, Nottingham NG7 2RD, England
[3] Hosp Clin Barcelona, Serv Immunol, IDIBAPS, Barcelona, Spain
关键词
hepatitis A virus; multiple antigenic peptide; peptide synthesis; liposome; enzyme-linked immunosorbent assay; surface plasmon resonance;
D O I
10.1016/S0014-5793(03)00249-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Multiple antigen peptides (MAP) have been demonstrated to be efficient immunological reagents for the induction of immune responses to a variety of infectious agents. Several peptide domains of the hepatitis A virus (HAV) capsid proteins, mainly VP1 and VP3, are the immunodominant targets for a protective antibody response. In the present study we analyse the immunogenic properties of a tetrameric heterogeneous palmitoyl-derivatised MAP containing two defined HAV peptide sequences, VP1(11-25) and VP3(102-121), in rabbits immunised with either Freund's adjuvant or multilamellar liposomes. The immune response was evaluated with a specific enzyme immunoassay using MAP[VP1+VP3], VP1 and VP3 as targets. The avidity of the immune response was measured by a noncompetitive enzyme-linked immunosorbent assay and by the surface plasmon resonance technology. Antisera raised against the lipo-MAP peptide entrapped in liposomes demonstrated high avidity of binding with affinity rate constants approximately one order of magnitude greater than those obtained with the Freund's protocol. (C) 2003 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:133 / 140
页数:8
相关论文
共 35 条
[1]  
ALTSCHUH D, 1982, BIOCHEMISTRY-US, V31, P6298
[2]   LIPOSOMES AS CARRIERS OF ANTIGENS AND ADJUVANTS [J].
ALVING, CR .
JOURNAL OF IMMUNOLOGICAL METHODS, 1991, 140 (01) :1-13
[3]   MEASUREMENT OF MONOCLONAL-ANTIBODY AFFINITY BY NONCOMPETITIVE ENZYME-IMMUNOASSAY [J].
BEATTY, JD ;
BEATTY, BG ;
VLAHOS, WG .
JOURNAL OF IMMUNOLOGICAL METHODS, 1987, 100 (1-2) :173-179
[4]   High immunogenicity in chimpanzees of peptides and lipopeptides derived from four new Plasmodium falciparum pre-erythrocytic molecules [J].
Benmohamed, L ;
Thomas, A ;
Bossus, M ;
Brahimi, K ;
Wubben, J ;
Gras-Masse, H ;
Druilhe, P .
VACCINE, 2000, 18 (25) :2843-2855
[5]  
Bosch A, 1998, J MED VIROL, V54, P95, DOI 10.1002/(SICI)1096-9071(199802)54:2<95::AID-JMV5>3.0.CO
[6]  
2-J
[7]   A NOVEL LYSINE-PROTECTING PROCEDURE FOR CONTINUOUS-FLOW SOLID-PHASE SYNTHESIS OF BRANCHED PEPTIDES [J].
BYCROFT, BW ;
CHAN, WC ;
CHHABRA, SR ;
HONE, ND .
JOURNAL OF THE CHEMICAL SOCIETY-CHEMICAL COMMUNICATIONS, 1993, (09) :778-779
[8]  
Chan W., 1999, Fmoc solid phase peptide synthesis: a practical approach
[9]   Effect of adjuvant composition on immune response to a multiple antigen peptide (MAP) containing a protective epitope from Neisseria meningitidis class 1 porin [J].
Christodoulides, M ;
Rattue, E ;
Heckels, JE .
VACCINE, 1999, 18 (1-2) :131-139
[10]   Comparative efficiency of simple lipopeptide constructs for in vivo induction of virus-specific CTL [J].
Deprez, B ;
Sauzet, JP ;
Boutillon, C ;
Martinon, F ;
Tartar, A ;
Sergheraert, C ;
Guillet, JG ;
Gomard, E ;
GrasMasse, H .
VACCINE, 1996, 14 (05) :375-382